BROWSE·page 1 of 12

Browse EX-10 agreements

137 matching material contract exhibits.


EXHIBIT 10.1

Translational Development Acquisition Corp.

Certain information marked with [***] has been excluded from this exhibit because it is not material and is the type that the registrant treats as private or confidential.

SUBSCRIPTION AGREEMENT

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”), dated as of July 27th, 2026, is entered into by and among Translational Development Acquisition Corp., a Cayman Islands blank check company (the “Issuer”), Prologium Holding Inc., a Cayman Islands exempted company (the “Company”) and the undersigned (“Subscriber” or “you”). Defined terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Business Combination Agreement (as defined below).

EX-10.1·425·CIK 1926599·ACC 0001104659-26-087089·Filed Jul 27, 2026, 16:08 ET

EXHIBIT 10.1

Solstice Advanced Materials Inc.

Execution Version

FIRST AMENDMENT TO CREDIT AGREEMENT

This FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), is entered into as of July 24, 2026, among Solstice Advanced Materials Inc., a Delaware corporation (the “Borrower”), the Lenders (as defined below) party hereto (the “Consenting Lenders”), and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”).

W I T N E S S E T H:

WHEREAS the Borrower, the Administrative Agent, the several lenders and issuing banks from time to time party thereto (the “Lenders”), are party to that certain Credit Agreement, dated as of October 29, 2025 (as amended, restated, amended and restated or otherwise modified or supplemented prior to the date hereof, the “Credit Agreement” and as amended by this Amendment, the “Amended Credit Agreement”).

EX-10.1·425·CIK 2064953·ACC 0001104659-26-086880·Filed Jul 27, 2026, 09:02 ET

EXHIBIT 10.1

Cartesian Growth Corp II

EXECUTION VERSION

SPONSOR SUPPORT AGREEMENT

This SPONSOR SUPPORT AGREEMENT is made and entered into as of July 24, 2026 (this “Agreement”), by and between CGC II Sponsor LLC, a Cayman Islands limited liability company (“Sponsor”) and InoBat AS, a private limited company (aksjeselskap) organized under the laws of Norway (the “Company”).

WHEREAS, Cartesian Growth Corporation II, an exempted company incorporated under the Laws of the Cayman Islands (“CGC”) and the Company propose to enter into, contemporaneously herewith, that certain Business Combination Agreement, dated as of the date hereof (the “BCA”; terms used but not defined in this Agreement shall have the meanings ascribed to them in the BCA);

WHEREAS, as of the date hereof, Sponsor owns beneficially and of record 5,649,999 CGC Class A Shares and one (1) CGC Class B Share (collectively, the “Sponsor Shares”); and

WHEREAS, as of the date hereof, Sponsor owns beneficially and of record 6,600,000 CGC Warrants (the “CGC Private Warrants”).

EX-10.1·425·CIK 1889112·ACC 0001104659-26-086863·Filed Jul 27, 2026, 08:18 ET

EXHIBIT 10.2

Cartesian Growth Corp II

EXECUTION VERSION

SHAREHOLDER SUPPORT AGREEMENT

This SHAREHOLDER SUPPORT AGREEMENT is made and entered into as of July 24, 2026 (this “Agreement”), by and among Cartesian Growth Corporation II, an exempted company incorporated under the Laws of the Cayman Islands (“CGC”), InoBat AS, a private limited company (aksjeselskap) organized under the laws of Norway and registered with registration number 927 439 948 in the Norwegian Register of Business Enterprises (the “Company”), and certain shareholders of the Company, whose names appear on the signature pages of this Agreement (each a “Shareholder” and, collectively, the “Shareholders”).

WHEREAS, CGC and the Company propose to enter into, contemporaneously herewith, that certain Business Combination Agreement, dated as of the date hereof (the “BCA”; terms used but not defined in this Agreement shall have the meanings ascribed to them in the BCA); and

EX-10.2·425·CIK 1889112·ACC 0001104659-26-086863·Filed Jul 27, 2026, 08:18 ET

EXHIBIT 10.3

Cartesian Growth Corp II

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of July 24, 2026, by and among Cartesian Growth Corporation II, a Cayman Islands exempted company (“CGC”), InoBat AS, a private limited company (aksjeselskap) organized under the Laws of Norway (the “Target”), CGC II Sponsor LLC, a Cayman Islands limited liability company and sponsor of the Company (the “Sponsor”) and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).

WHEREAS, promptly after the date of this Agreement, the Target will form InoBat B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) to be incorporated and existing under the laws of the Netherlands (the “Company”), and the Company will become a party to this Agreement;

EX-10.3·425·CIK 1889112·ACC 0001104659-26-086863·Filed Jul 27, 2026, 08:18 ET

Confidential

Final Form

Amendment No. 1 to the
SECURITIES
** PURCHASE AGREEMENT**

This **AMENDMENT NO. 1 **(this “Amendment”) to that certain Securities Purchase Agreement, dated as of May 19, 2026 (the “Agreement”), by and among Mentari Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on the signature pages thereto (each, a “Original Investor” and together the “Original Investors”) is made and entered into as of July 22, 2026 by and among the Company, each of the Original Investors listed on Schedule I attached to this Amendment, and each of the Persons listed on Schedule II attached to this Amendment (each, an “New Investor” and together, the “New Investors”). Capitalized terms used but not defined in this Amendment shall have the meanings given to such terms in the Agreement.

** **

EX-10.1·425·CIK 1728328·ACC 0001213900-26-080417·Filed Jul 22, 2026, 16:30 ET

* *

Execution Version

** **

**SUBSCRIPTION AGREEMENT **

This SUBSCRIPTION AGREEMENT (this “Subscription Agreement”) is entered into as of July 21, 2026, by and between Apex Treasury Corporation, a Cayman Islands exempted company (the “Company”), and the undersigned (“Subscriber” or “you”). Defined terms used but not otherwise defined herein shall have the respective meanings ascribed thereto in the Transaction Agreement (as defined below).

EX-10.1·425·CIK 2079253·ACC 0001213900-26-080202·Filed Jul 22, 2026, 08:37 ET

Execution Version

Stockholder SUPPORT AGREEMENT

This STOCKHOLDER SUPPORT AGREEMENT, dated as of July 21, 2026 (this “Agreement”), by and among Apex Treasury Corporation, a Cayman Islands exempted company (“Purchaser”), TECfusions, Inc., a Florida corporation (the “Company”), and Jeremiah 29:11, LLC, a Florida limited lability company (the “Signing Stockholder”). Purchaser, the Company and the Signing Stockholder are sometimes referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

EX-10.2·425·CIK 2079253·ACC 0001213900-26-080202·Filed Jul 22, 2026, 08:37 ET

Execution Version

SPONSOR SUPPORT AGREEMENT

This SPONSOR SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of July 21, 2026, by and among Apex Treasury Corporation, a Cayman Islands exempted company (“Purchaser”), TECfusions, Inc., a Florida corporation (the “Company”), Apex Treasury Sponsor LLC (“Sponsor”) and each of the other shareholders of Purchaser listed under Exhibit A attached hereto (together with Sponsor, each a “Signing Shareholder” and collectively, the “Signing Shareholders”). Purchaser, the Company and each Signing Shareholder are sometimes referred to herein as a “Party” and collectively as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

** **

RECITALS

EX-10.3·425·CIK 2079253·ACC 0001213900-26-080202·Filed Jul 22, 2026, 08:37 ET

EX-10.5

Glucotrack, Inc.

** **

Exhibit 10.5

** **

REGISTRATION RIGHTS AGREEMENT

** **

This Registration Rights Agreement (this “Agreement”) is entered into effective as of July 14, 2026 (the “Execution Date”), by and between Glucotrack, Inc., a Delaware corporation (the “Company”), and White Lion Capital, LLC, a Nevada limited liability company (the “Investor”).

RECITALS

** **

A. WHEREAS, in connection with the Common Stock Purchase Agreement, dated as of July 14, 2026, by and between the Company and the Investor (the “Purchase Agreement”), the Company may issue and sell to the Investor, from time to time, and the Investor shall purchase from the Company, up to $50,000,000 in aggregate gross purchase price of newly issued Purchase Notice Shares;

B. WHEREAS, in consideration for the Investor’s execution and delivery of the Purchase Agreement, the Company shall issue to the Investor the Commitment Shares and the Commitment Warrant (each as defined in the Purchase Agreement),

EX-10.5·425·CIK 1506983·ACC 0001493152-26-033395·Filed Jul 15, 2026, 17:20 ET

EX-10.1

Glucotrack, Inc.

** **

Exhibit 10.1

** **

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of July 14, 2026, by and between Glucotrack, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”), and the investors named on the signature pages annexed hereto (collectively, the “Investors”).

BACKGROUND

A. The board of directors (the “Board of Directors”) of the Company has authorized the issuance to the Investors of certain Notes (as defined below) and Warrants (as defined below).

B The Investor desires to purchase the Note on the terms and conditions set forth in this Agreement.

NOW THEREFORE, in consideration of the foregoing recitals and the covenants and agreements set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

EX-10.1·425·CIK 1506983·ACC 0001493152-26-033395·Filed Jul 15, 2026, 17:20 ET

EX-10.3

Glucotrack, Inc.

VOTING SUPPORT AGREEMENT

THIS VOTING SUPPORT AGREEMENT, dated as of July __, 2026 (this “Agreement”), is entered into by and among the investors listed on the signature page hereto (collectivity, the “Investor”), and each of the individuals or entities listed on the signature pages hereto (each, a “Stockholder” and, together, the “Stockholders”).

RECITALS

**A. **Concurrently with the execution and delivery of this Agreement, Glucotrack, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”), is entering into that certain Securities Purchase Agreement, dated as of July 14, 2026, by and among the Company and the Investor (the “Purchase Agreement”), pursuant to which the Company will issue and sell to the Investor senior secured convertible promissory notes (collectively, the “Note”) and warrants to purchase shares of Common Stock (as defined in the Purchase Agreement) of the Company (the “Warrants”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Purchase Agreement.

EX-10.3·425·CIK 1506983·ACC 0001493152-26-033395·Filed Jul 15, 2026, 17:20 ET